دورية أكاديمية
Phase I open-label study of cediranib, an oral inhibitor of VEGF signalling, in combination with the oral Src inhibitor saracatinib in patients with advanced solid tumours
| العنوان: | Phase I open-label study of cediranib, an oral inhibitor of VEGF signalling, in combination with the oral Src inhibitor saracatinib in patients with advanced solid tumours |
|---|---|
| المؤلفون: | Trarbach, Tanja, Schultheis, Beate, Gauler, Thomas C., Schneider, Vesile, Strumberg, Dirk, Eberhardt, Wilfried E. E., Le Scouiller, Stephanie, Marotti, Marcelo, Brown, Kathryn H., Drevs, Joachim |
| المصدر: | Investigational New Drugs: The Journal of New Anticancer Agents. October 2012 30(5):1962-1971 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 01676997 15730646 |
|---|---|
| DOI: | 10.1007/s10637-011-9754-x |